The global analgesics market comprises pain relieving medications including non-opioids and opioids. Non-opioid analgesics include acetaminophen, NSAIDs, and others. They effectively reduce fever or mild to moderate pain associated with conditions like headaches, back pain, arthritis, menstrual cramps etc. Opioid analgesics help manage severe chronic pain and act on opioid receptors in the central nervous system. The growing burden of chronic conditions causing persistent pain such as arthritis, cancer and musculoskeletal disorders is driving massive demand for analgesics worldwide. The Global Analgesics Market is estimated to be valued at US$ 51.10 Bn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global analgesics are F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin. The key players are focused on developing novel delivery systems, fixed dose combinations and establishing collaborations for stronger market presence. The rising prevalence of chronic diseases is generating high demand for pain relief especially in developing nations. Development of cheaper generic versions of patented drugs also provides opportunities for market players. With a growing geriatric population worldwide, the Global Analgesics Market Size is expected to witness significant expansion internationally. Asian and Latin American countries in particular show lucrative prospects owing to improving access to healthcare and economic growth. Market drivers: The significant increase in prevalence of various chronic pain indications such as low back pain, osteoarthritis, cancer pain etc. is the major market driver. It is estimated that over 1.5 billion people suffer from chronic pain globally. The increasing life expectancy also leads to higher chronic disease burden boosting analgesic sales. Promotion of non-opioid alternatives and novel drug delivery systems further support market growth over the coming years.
PEST Analysis Political: Regulations around prescription and over-the-counter drugs have a significant impact on the analgesics market. Regulations aim to ensure safety and efficacy of drugs. Economic: Changes in disposable incomes influence demand for pain relief options. Higher incomes allow people to opt for advanced pain management solutions. Recession impacts non-essential healthcare spending. Social: Growing health awareness and easier access to medicines are increasing analgesic usage. Self-medication trends are rising. An aging population also drives demand for pain relief. Technological: Advanced drug delivery systems and pain relief applications using technologies like virtual reality are gaining prominence. 3D printing could impact drug development and manufacturing. Technology advances help address unmet needs. North America accounts for the largest share of the global analgesics market in terms of value. The availability of reimbursement policies and well-developed healthcare infrastructure drive market growth in the region. The Asia Pacific region is expected to witness the fastest growth in the analgesics market during the forecast period. Factors such as improving access to healthcare facilities, increasing incomes, growing medical tourism, and rising awareness regarding pain management are expected to support the growth of the analgesics market in emerging Asia Pacific countries. The global analgesics market is fairly consolidated in nature with a few large players dominating the market. Intense competition exists among key players to acquire smaller companies and promote their product offerings. Companies focus on developing innovative products through extensive R&D to gain market share.
Get this Report in Japanese Language- 鎮痛剤の世界市場
Get this Report in Korean Language- 글로벌 진통제 시장
About Author-
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
